Janux Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$14.99

+0.08 (+0.54%)

As of Jun 24, 2:25 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 21 81%

Hold 4 15%

Sell 1 4%

Price Target

Analyst Price Target +227.6% upside

Low Target $33.46

Average Target $49.10

High Target $61.24

Current Price $14.99

Current
$14.99

Target
$49.10

$33.46 $49.10 avg $61.24

Scenario Analysis

Bear Case

$33.46

123.2%

Low target

Base Case

$49.10

+227.6%

Avg target

Bull Case

$61.24

+308.5%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$35.34

-57.6% from high

52-Week Low

$12.12

+23.7% from low

Target vs 52W High

$49.10

+38.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%